Loading market dashboard
UnitedHealth Group Incorporated
UNHHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
This ETF's dividend yield was recently a solid 3.25%, about three times that of the S&P 500. Its growth rate has been better than that of many dividend-focused funds.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
UnitedHealth Group (UNH, Financials) and Eli Lilly (LLY, Financials) are emerging as leaders in a renewed healthcare sector rally as investors increasingly rota
Shares of UnitedHealth Group Incorporated UNH have gained 20.1% year to date, beating the industry's 13.8% gain and the S&P 500's 10.2% rise. The rebound is notable given the challenges hanging over the company.
Explore how sector weightings and stock selection shape risk and return for these two leading dividend ETFs, each with distinct strategies and top holdings.
Morgan Stanley names UnitedHealth its top managed care pick, citing AI-driven growth, efficiency gains and improving operations.
Lowe's, Medtronic, and UnitedHealth Group have been solid dividend growth stocks over the years. They offer above-average payouts and their valuations are also attractive.
UnitedHealth stock continues to strengthen following a major bottom breakout, with a bull flag continuation pattern signaling potential upside toward higher retracement targets.
Shares of UnitedHealth Group UNH rallied sharply on Thursday after a pair of bullish analyst notes reinforced growing optimism that the health insurer's turnaround is gaining momentum. UnitedHealth stock climbed more than 5% in trading, helping lift the Dow Jones Industrial Average higher even as broader markets traded mixed.
UnitedHealth Group (UNH) shares rose 5% on Thursday after Bank of America raised its rating on the managed care company to Buy from Neutral, citing a more favor
UNH raises its dividend again, extending a long streak of annual increases despite a smaller hike.
Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.
UnitedHealth Group's stock is rallying Thursday, leading the Dow Jones Industrial Average higher on a mixed day for the major indexes after a fresh vote of confidence on Wall Street.
UnitedHealth Group's stock is rallying Thursday, leading the Dow Jones Industrial Average higher on a mixed day for the major indexes after a fresh vote of confidence on Wall Street.
Insurance giant UnitedHealth Group Inc. (NYSE:UNH) stock is surging on Thursday. Over the last six months, the stock has gained almost 20%.
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares rose more than 5% to about $397 on Thursday after Bank of America upgraded the stock to ‘Buy,' citing improving medical cost trends and a more favorable risk-reward setup heading into upcoming earnings. The firm also raised its price target to $450 and lifted earnings estimates for 2026 and 2027.
Shares of UnitedHealth Group receive votes of confidence from analysts at BofA Securities and Morgan Stanley.
Warsh's policies could hurt some stocks, but not these three.
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares rose more than 5% to about $397 on Thursday after Bank of America upgraded the stock to ‘Buy,’ citing...
UnitedHealth Group Inc (NYSE:UNH) is higher in premarket trading, up 2.7% at $387.01, after Bank of America upgraded the health insurer to "buy" from "neutral" and lifted its price target to $450 from $420.
Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Arm Holdings' management reiterated confidence in sustaining approximately 20% royalty growth longer term, reinforcing the market's confidence in Arm's structural growth profile. Adyen was a detractor from performance during the quarter following fourth quarter results and a more cautious 2026 outlook. We initiated a new position in American Express and exited our positions in Gartner and UnitedHealth.
UnitedHealth Group (NYSE: UNH) provided updates on its 2026 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected c
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) provided updates on its 2026 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Scott Gottlieb, M.D., Stephen Hemsley, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as.
UnitedHealth generated $8.9 billion in Q1 operating cash flow, funding buybacks, debt reduction, dividends, and acquisitions. UNH management plans at least $2 billion of share repurchases by June 2026 while targeting further balance-sheet improvement. AI investments of $1.5 billion reduced manual contact costs by 76% and improved claims processing efficiency.
CVS Health may beat UnitedHealth Group in terms of forward dividend yield, but when it comes to dividend growth, it's no contest. UnitedHealth Group has raised its dividend during each of the past 16 years, while CVS hasn't raised its payout in over two years.
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) is a stock worth owning for decades because the aging of America makes its cash flows close to legislatively guaranteed, and almost nothing in the public markets matches the combination of scale, integration, and shareholder return discipline this company has built around that demographic certainty.
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
The Ninth Circuit is urged to reject UnitedHealthcare's alleged deceptive Medicare Advantage advertising and use of preemption to circumvent state laws
On June 01, 2026, we delve into the DCF analysis for UnitedHealth Group Inc (UNH), a company that has shown notable price performance over the past year with a
Oscar Health's tech-driven growth contrasts with UnitedHealth's massive scale and diversified revenue.
Massachusetts sued a UnitedHealth unit on Friday, accusing it of defrauding the state's Medicaid program MassHealth out of at least $100 million.
UnitedHealth Group plans to stop requiring doctors to get approvals for an array of pediatric procedures, tests and services, further cutting back on a process that has long been detested by physicians and patients.
UnitedHealth's insurance unit on Friday said it would eliminate prior approval requirements for about two-thirds of its healthcare services for members under age 18, as insurers aim to reduce delays and paperwork amid complaints from patients and doctors.
UnitedHealthcare, the nation's largest health insurance company, said it is “removing two-thirds of authorization requirements” for health plan members under age 18 by the end of this year.
UnitedHealthcare is removing two-thirds of authorization requirements for members under age 18 by year's end. This move is the latest in a series of initiative
--(BUSINESS WIRE)--UnitedHealthcare is removing two-thirds of authorization requirements for members under age 18 by year's end. This move is the latest in a series of initiatives to simplify the healthcare system for providers and patients. The company is eliminating prior authorizations for many diagnostic services, routine surgical procedures and specialty care services across pediatric subspecialties such as cardiology, neurology, pulmonology and orthopedics. UnitedHealthcare is also introd.
When choosing dividend ETFs, diversification is a top priority.
MOH's Medicaid focus, dual-eligible expansion and stronger share gains make it stand out against UNH in managed care.
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Berkshire cashed out of UnitedHealth before the recent rally, but that doesn't mean Abel sold too early.
Coleman and Tepper sold UnitedHealth Group stock in Q1. However, Wall Street analysts remain overwhelmingly bullish about the health insurance stock.
On May 26, 1896, Charles Dow calculated a simple arithmetic average of 12 industrial stocks and arrived at a closing value of 40.94. Now, exactly 130 years later, that same benchmark has crossed the historic 50,000 threshold.
Innovation, regulatory policy, and demographics are driving healthcare stocks higher. Healthcare companies have also posted strong first-quarter results.
UnitedHealth has engineered a turnaround, in part by adopting AI tools.
According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee.
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Mizuho raised its price target on UnitedHealth Group (NYSE:UNH | UNH Price Prediction) to $440 from $410 and kept an Outperform rating on the managed care leader.
Wall Street analysts are projecting that healthcare giant UnitedHealth (NYSE: UNH) stock is likely to see further momentum over the next 12 months.
UNH is under the spotlight after Berkshire Hathaway's 13F reveals it exited its entire stake, sparking surprise selling and fresh scrutiny on headwinds.
UnitedHealth Group (UNH, Financials) shares moved lower after Berkshire Hathaway disclosed it had exited its position in the health insurer.The stock fell as mu
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.
Fox News contributor Donna Rotunno discusses the trial following the killing of UnitedHealthcare CEO Brian Thompson on 'The Bottom Line.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #thebottomline #luigimangione #mangione #brianthompson #unitedhealthcare #ceo #trial #court #evidence #government #prosecutors #crime #crimenews #crimestory #criminal #police #murder #law #attorney
The Oracle of Omaha may not be calling the shots anymore, but Berkshire Hathaway's stock picks can still move markets.
Shares of UnitedHealth Group fell over 2% on Monday after Berkshire Hathaway disclosed that it had exited its entire position in the health insurer during the first quarter, ending a brief but closely watched investment. The healthcare giant's stock had recently staged a strong rebound, posting its seventh consecutive weekly gain after rising about 4% last week.
UnitedHealth Group Inc. (NYSE:UNH) stock is trading lower during Monday's premarket session following Berkshire Hathaway's (NYSE:BRK) (NYSE:BRK)disclosure that it liquidated its entire position in the U.S. insurance giant.
UnitedHealth shares fell 3% on Monday after Berkshire Hathaway disclosed it had sold its stake in the healthcare conglomerate as a part of a portfolio reshuffling in the first quarter under CEO Greg Abel.
--(BUSINESS WIRE)--UnitedHealthcare Community Plan of D.C. has earned the Long-Term Services and Supports (LTSS) Distinction by the National Committee for Quality Assurance (NCQA). NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA's LTSS Distinction offers a person-centered, comprehensive and standardized evaluation of organizations responsible for delivering managed long-term services and supports. LTSS Distinction is specifically designed for organiza.
Nvidia set to unveil Q1 results, Greg Abel reshapes Berkshire's holdings, and more
